Skip to main content
S.C.P.C logo

S.C.P.C — Investor Relations & Filings

Ticker · 1720 ISIN · TW0001720001 TW Manufacturing
Open in API
Filings indexed 1,621 across all filing types
Latest filing 2022-12-09 Regulatory Filings
Country TW Taiwan
Listing TW 1720

About S.C.P.C

http://www.standard.com.tw

Standard Chemical & Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical manufacturer established in 1967. The company specializes in the research, development, production, and marketing of a wide range of pharmaceutical products, including generic Western medicines, Active Pharmaceutical Ingredients (APIs), and healthcare supplements. Its therapeutic portfolio covers diverse areas such as cardiovascular, metabolic, respiratory, anti-infective, and musculoskeletal systems, as well as dermatological and urogenital treatments. As a prominent generic drug manufacturer, the company operates with an integrated business model that spans from high-tech R&D to brand management and distribution. Adhering to international quality standards and ISO 9001 certification, it focuses on technological innovation and sustainable growth to serve diverse healthcare needs across domestic and international markets.

Recent filings

Filing Released Lang Actions
111年11月營業收入
Regulatory Filings Classification · 90% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 生達, presented in a tabular format with explanations about accounting standards and reporting practices. It contains specific financial data for November of the 111th year of the Republic of China calendar (equivalent to 2022) and cumulative figures for the year. The document is short (776 characters) and focuses on revenue figures and percentage changes, without detailed financial statements or comprehensive analysis. It does not appear to be a full annual or interim report, nor an earnings release with highlights. It is more of a periodic financial data disclosure, likely a regulatory filing of summarized financial information. Given the lack of detailed financial statements or management discussion, and the short length, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2022-12-09 Chinese
代子公司Standard Pharmaceutical Co., Ltd. 公告資金貸與 達「公開發行公司資金貸與及背書保證處理準則」第22條 第1項第3款之公告標準
Capital/Financing Update Classification · 95% confidence The document is a regulatory announcement from a listed company (1720 生達) regarding a capital loan to its wholly owned subsidiary. It details the loan amount, interest rate, repayment terms, and financial status of the borrowing subsidiary. The content focuses on a financing activity (capital loan) and complies with disclosure regulations. The document length is short (1124 characters) and it is not a full financial report but an update on financing activity. Therefore, it fits best under Capital/Financing Update (CAP).
2022-11-23 Chinese
111年11月法人說明會簡報 — 172020221116E002.pdf
Interim / Quarterly Report Classification · 95% confidence The document is a detailed presentation from Standard Chem & Pharm Co., Ltd. dated November 17, 2022, titled '2022 Investor Conference'. It includes forward-looking statements, an agenda, consolidated income statements, balance sheets, cash flow statements, and discussion of operating results for Q1-Q3 2022. The content covers financial performance, future strategy, and corporate social responsibility. The presence of detailed financial data for a partial fiscal year (Q1-Q3) and strategic discussion indicates this is a comprehensive interim or quarterly report rather than a brief earnings release or investor presentation. The length (15,000 characters) and detailed financial tables confirm it is a substantive financial report. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2022-11-16 Chinese
111年11月法人說明會簡報 — 172020221116M002.pdf
Investor Presentation Classification · 95% confidence The document is a detailed presentation from Standard Chem & Pharm Co., Ltd. dated November 17, 2022, covering the company's business overview, financial results for the first three quarters of 2022, future strategies, and corporate social responsibility. It includes consolidated income statements, balance sheets, cash flow statements, and market trend analysis. The content is structured as a presentation with slides and charts, typical of investor presentations. It is not a full annual or quarterly report filing, nor is it an earnings release or regulatory filing. The presence of forward-looking statements and strategic discussion further supports classification as an investor presentation rather than a formal financial report or regulatory announcement.
2022-11-16 Chinese
111年11月法人說明會簡報
Investor Presentation Classification · 95% confidence The document is a listing from a public information observation station showing details about a company's investor conference call or presentation, including date, time, location, summary of the meeting, and links to presentation materials and video. The content focuses on a '法人說明會' which translates to 'investor presentation' or 'analyst meeting'. The document length is short (1157 characters) and it provides links to presentation PDFs and video, indicating it is an announcement or summary of an investor presentation event rather than the full transcript or report. Therefore, the document best fits the category of Investor Presentation (IP).
2022-11-16 Chinese
公告本公司召開法人說明會相關資訊
Investor Presentation Classification · 95% confidence The document is a short announcement (667 characters) about the scheduling of a '法人說明會' (investor presentation) including date, time, location, and a brief summary of the topics to be discussed (2022 Q3 operational overview). It does not contain actual financial statements or detailed financial data, but rather informs about the upcoming investor presentation event. According to the 'MENU VS MEAL' rule, this is an announcement of a presentation, not the presentation itself. Therefore, the appropriate classification is 'Investor Presentation' (IP). Confidence is high given the clear description and typical format of such announcements.
2022-11-15 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.